No publishable AOV benchmark
Explore category insights and their sources below.
Madgicx Research & Labs
Instrument procurement depends on the reuse specification.
Explore category insights and their sources below.
Within Medical Equipment & Supplies
FDA's US overview identifies reusable devices such as surgical forceps and says reprocessing follows manufacturer labeling. It treats reusable-device reprocessing separately from single-use devices. Name the instrument and its labeled use category in a procurement offer; appearance alone is not evidence of a reusable specification.
FDA describes device-specific US reprocessing regimens. Cleaning is followed by disinfection or sterilization as appropriate to intended use and materials. An offer should reference the device-specific reprocessing requirements rather than promise that one process suits every instrument.
FDA's US reprocessing overview places repeated cleaning and subsequent processing within the device's required regimen, with trained staff working in different healthcare settings. Suggested procurement practice: clarify the supplied instructions and the buyer's processing workflow before equating an instrument enquiry with a ready-to-use supply.
FDA's US single-use reprocessing page says not all single-use devices are suitable for reprocessing. Hospital and third-party reprocessors must meet applicable FDA requirements, including validation and maximum-cycle requirements where relevant. Regulated reprocessing is a separate offer; ordinary cleaning alone does not establish that status.
No publishable AOV benchmark is available.
The exact category cohort does not support a publishable AOV aggregate. Parent and sibling benchmarks are not substituted.
The exports section provides this edition in Markdown and JSON, along with a research index. This private draft is not licensed for public redistribution.
When reuse is permitted, credit Madgicx Research & Labs and link to the exact source. Keep its snapshot date and scope. This private draft is not licensed for public redistribution.
Research scope
Benchmark status reviewed 11 October 2026.
The exact category cohort does not support a publishable AOV aggregate.
Median and middle 50% of account-level average order values. Each account value is purchase ROAS multiplied by cost per purchase in USD. Successful classifications, including manual corrections, with positive finite spend, purchases, ROAS and cost per purchase. Accounts are counted once with equal weight. Quartiles use linear interpolation. Root cohorts include direct root classifications and their child categories; exact-child cohorts exclude parent and sibling categories. The source selects the highest-spend coverage row per account among snapshots dated within the preceding 30 days; the underlying reporting period is not supplied. This is a dated aggregate advertising-data snapshot, not business-wide AOV or a census. Parent and sibling benchmarks are never substituted.
Individually authored category research. The brand directory is deferred for this private draft. Taxonomy membership does not establish benchmark coverage.
When reuse is permitted, credit Madgicx Research & Labs and link to the exact source. Keep its snapshot date and scope. This private draft is not licensed for public redistribution.